A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors

[1]  Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with , 2017 .

[2]  David M Sabatini,et al.  Large-Scale Single Guide RNA Library Construction and Use for CRISPR-Cas9-Based Genetic Screens. , 2016, Cold Spring Harbor protocols.

[3]  J. Young,et al.  Cytosolic sulfotransferase 1A1 regulates HIV-1 minus-strand DNA elongation in primary human monocyte-derived macrophages , 2016, Virology Journal.

[4]  A. Engelman,et al.  A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin , 2016, Proceedings of the National Academy of Sciences.

[5]  Trevor Bedford,et al.  Persistent HIV-1 replication maintains the tissue reservoir during therapy , 2015, Nature.

[6]  M. Altfeld,et al.  Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01 , 2015, PloS one.

[7]  D. Durocher,et al.  High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.

[8]  Stephen H Hughes,et al.  LEDGF/p75 interacts with mRNA splicing factors and targets HIV-1 integration to highly spliced genes , 2015, Genes & development.

[9]  Tonia K. Tsinman,et al.  The CENP-L-N Complex Forms a Critical Node in an Integrated Meshwork of Interactions at the Centromere-Kinetochore Interface. , 2015, Molecular cell.

[10]  E. Lander,et al.  Identification and characterization of essential genes in the human genome , 2015, Science.

[11]  R. Sanjuán,et al.  Extremely High Mutation Rate of HIV-1 In Vivo , 2015, PLoS biology.

[12]  Jennifer A. Doudna,et al.  Generation of knock-in primary human T cells using Cas9 ribonucleoproteins , 2015, Proceedings of the National Academy of Sciences.

[13]  S. Gygi,et al.  A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion , 2015, Science.

[14]  Walther Mothes,et al.  HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy. , 2015, Trends in microbiology.

[15]  J. Hoxie,et al.  Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques , 2015, Nature Methods.

[16]  Baoshan Zhang,et al.  AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges , 2015, Nature.

[17]  K. Anastos,et al.  JAM‐A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV‐infected individuals , 2015, Journal of leukocyte biology.

[18]  C. Buchrieser,et al.  Legionella pneumophila type IV effectors hijack the transcription and translation machinery of the host cell. , 2014, Trends in cell biology.

[19]  John A. Young,et al.  Sulfonation pathway inhibitors block reactivation of latent HIV-1. , 2014, Virology.

[20]  A. Brass,et al.  Comprehensive Identification of Host Modulators of HIV-1 Replication using Multiple Orthologous RNAi Reagents , 2014, Cell reports.

[21]  K. Anderson,et al.  Current Perspectives on HIV-1 Antiretroviral Drug Resistance , 2014, Viruses.

[22]  C. Figdor,et al.  Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6 , 2014, Journal of Cell Science.

[23]  Wei-Ting Hwang,et al.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. , 2014, The New England journal of medicine.

[24]  P. Brown,et al.  Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2–V3 interaction and modulates neutralization sensitivity , 2014, Proceedings of the National Academy of Sciences.

[25]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[26]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[27]  H. Lortat-Jacob,et al.  Human Immunodeficiency Virus and Heparan Sulfate: From Attachment to Entry Inhibition , 2013, Front. Immunol..

[28]  E. Domae,et al.  ICAM-1–Dependent Homotypic Aggregates Regulate CD8 T Cell Effector Function and Differentiation during T Cell Activation , 2013, The Journal of Immunology.

[29]  Pablo Tamayo,et al.  ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens , 2013, Genome research.

[30]  C. Halin,et al.  Novel role for ALCAM in lymphatic network formation and function , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  D. Richman,et al.  Rates of Emergence of HIV Drug Resistance in Resource-Limited Settings: A Systematic Review , 2012, Antiviral therapy.

[32]  W. Kaelin,et al.  Use and Abuse of RNAi to Study Mammalian Gene Function , 2012, Science.

[33]  J. Carette,et al.  Attachment of Chlamydia trachomatis L2 to host cells requires sulfation , 2012, Proceedings of the National Academy of Sciences.

[34]  John H. Morris,et al.  Global landscape of HIV–human protein complexes , 2011, Nature.

[35]  H. Ding,et al.  Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages , 2011, Journal of Virology.

[36]  J. Murray,et al.  Host factors mediating HIV-1 replication. , 2011, Virus research.

[37]  Ron Milo,et al.  Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy , 2011, Nature.

[38]  W. Greene,et al.  Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue , 2010, Cell.

[39]  E. Thiel,et al.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.

[40]  Michael T. McManus,et al.  Rapid Creation and Quantitative Monitoring of High Coverage shRNA Libraries , 2009, Nature Methods.

[41]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[42]  Carolyn R Bertozzi,et al.  Programmed assembly of 3-dimensional microtissues with defined cellular connectivity , 2009, Proceedings of the National Academy of Sciences.

[43]  Amy S. Espeseth,et al.  Genome-scale RNAi screen for host factors required for HIV replication. , 2008, Cell host & microbe.

[44]  B. Chait,et al.  Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases. , 2008, Biochemistry.

[45]  R. König,et al.  Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication , 2008, Cell.

[46]  Anders Karlsson,et al.  Maraviroc for previously treated patients with R5 HIV-1 infection. , 2008, The New England journal of medicine.

[47]  Junsang Doh,et al.  A synaptic basis for paracrine interleukin-2 signaling during homotypic T cell interaction. , 2008, Immunity.

[48]  C. Chien,et al.  Regulation of Zebrafish Skeletogenesis by ext2/dackel and papst1/pinscher , 2008, PLoS genetics.

[49]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[50]  B. Mittal,et al.  CCR5 Δ32 Polymorphism: Associated with Gallbladder Cancer Susceptibility , 2008, Scandinavian journal of immunology.

[51]  B. Fehse,et al.  A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[52]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[53]  B. Mittal,et al.  CCR5-Delta32 polymorphism and susceptibility to cervical cancer: association with early stage of cervical cancer. , 2008, Oncology research.

[54]  W. Hübner,et al.  Predominant Mode of Human Immunodeficiency Virus Transfer between T Cells Is Mediated by Sustained Env-Dependent Neutralization-Resistant Virological Synapses , 2007, Journal of Virology.

[55]  N. Sasaki,et al.  A mutation in Tpst2 encoding tyrosylprotein sulfotransferase causes dwarfism associated with hypothyroidism. , 2007, Molecular endocrinology.

[56]  R. Lechler,et al.  Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. , 2007, Blood.

[57]  O. Schwartz,et al.  Inefficient Human Immunodeficiency Virus Replication in Mobile Lymphocytes , 2006, Journal of Virology.

[58]  Scott D Emr,et al.  The ESCRT complexes: structure and mechanism of a membrane-trafficking network. , 2006, Annual review of biophysics and biomolecular structure.

[59]  C. Ballantyne,et al.  The LFA-1 Adhesion Molecule Is Required for Protective Immunity during Pulmonary Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[60]  Todd M. Allen,et al.  Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry. , 2006, Journal of virological methods.

[61]  D. McDermott,et al.  CCR5 deficiency increases risk of symptomatic West Nile virus infection , 2006, The Journal of experimental medicine.

[62]  Michael S Saag,et al.  Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1 , 2005, Nature Medicine.

[63]  M. Wainberg,et al.  Regulation of Human Immunodeficiency Virus Type 1 Gene Expression by Clade-Specific Tat Proteins , 2005, Journal of Virology.

[64]  N. Yamamoto,et al.  Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. , 2004, Molecular biology of the cell.

[65]  M. Llano,et al.  LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes , 2004, Journal of Virology.

[66]  D. Duffy,et al.  CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis. , 2004, Genes and immunity.

[67]  D. Duffy,et al.  CCR5-Δ32 mutation is strongly associated with primary sclerosing cholangitis , 2004, Genes and Immunity.

[68]  R. Ueda,et al.  Molecular Cloning and Identification of 3′-Phosphoadenosine 5′-Phosphosulfate Transporter* , 2003, Journal of Biological Chemistry.

[69]  B. Kyewski,et al.  Dynamic Changes During the Immune Response in T Cell–Antigen-presenting Cell Clusters Isolated from Lymph Nodes , 2003, The Journal of experimental medicine.

[70]  R. Doms,et al.  Identification of gp120 Binding Sites on CXCR4 by Using CD4-Independent Human Immunodeficiency Virus Type 2 Env Proteins , 2003, Journal of Virology.

[71]  W. Greene,et al.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes , 2002, Nature Biotechnology.

[72]  M. Cadene,et al.  Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[73]  G. Swart.  Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. , 2002, European journal of cell biology.

[74]  H. Yusuf-Makagiansar,et al.  Inhibition of LFA‐1/ICAM‐1 and VLA‐4/VCAM‐1 as a therapeutic approach to inflammation and autoimmune diseases , 2002, Medicinal research reviews.

[75]  C. Figdor,et al.  Molecular Basis for the Homophilic Activated Leukocyte Cell Adhesion Molecule (ALCAM)-ALCAM Interaction* , 2001, The Journal of Biological Chemistry.

[76]  D. Thompson,et al.  Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4. , 2000, Virology.

[77]  Z. Ding,et al.  Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. , 1999, Journal of immunology.

[78]  Joseph Sodroski,et al.  Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry , 1999, Cell.

[79]  C. Niehrs,et al.  Existence of distinct tyrosylprotein sulfotransferase genes: molecular characterization of tyrosylprotein sulfotransferase-2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[80]  M. Lai.  Cellular factors in the transcription and replication of viral RNA genomes: a parallel to DNA-dependent RNA transcription. , 1998, Virology.

[81]  C. Mackay,et al.  Interaction of Chemokine Receptor CCR5 with its Ligands: Multiple Domains for HIV-1 gp120 Binding and a Single Domain for Chemokine Binding , 1997, The Journal of experimental medicine.

[82]  A. Khoruts,et al.  In Vivo Detection of Dendritic Cell Antigen Presentation to CD4+ T Cells , 1997, The Journal of experimental medicine.

[83]  D. Durand,et al.  A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. , 1996, Transplantation.

[84]  B. Haynes,et al.  Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand , 1995, The Journal of experimental medicine.

[85]  Michael L. Dustin,et al.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1 , 1989, Nature.

[86]  W. Huttner,et al.  Chlorate--a potent inhibitor of protein sulfation in intact cells. , 1986, Biochemical and biophysical research communications.

[87]  R. Steinman,et al.  Clustering of dendritic cells, helper T lymphocytes, and histocompatible B cells during primary antibody responses in vitro , 1984, The Journal of experimental medicine.